China opposes planned U.S. visit by Taiwan vice president

BEIJING (Reuters) – China on Thursday said it firmly opposes any form of official exchange between the United States and Taiwan, and resolutely opposes “sneaky visits” by Taiwan “independence separatists”. China urges the U.S. to stop official U.S.-Taiwan contacts and to stop escalating U.S.-Taiwan “substantive” relations, the foreign ministry said in a statement. Taiwan Vice…

Read More

USA Today-publisher Gannett raises profit targets as ad demand rebounds

(Reuters) – USA Today-publisher Gannett Co boosted its annual earnings expectations on Thursday, as advertising demand recovers from post-pandemic lows. Advertising budgets were hit earlier this year by an uncertain economy as rapid interest rate hikes by the U.S. Federal Reserve to clamp inflation fueled fears of a recession. But cooling inflation has put ad…

Read More

Fed’s Barkin: Inflation still too high, hopes recent data is ‘a sign’

(Reuters) – U.S. inflation remains too high, although recent readings showing price pressures have eased notably were welcome, Richmond Federal Reserve President Thomas Barkin said on Thursday. “Certainly, last month’s inflation read was a good one and I hope it is a sign,” Barkin said in remarks prepared for a speech in Virginia. Barkin did…

Read More

Cummins misses profit expectations on high manufacturing costs

(Reuters) – Engine maker Cummins reported a second-quarter profit on Thursday that missed analysts’ estimates, hurt by high manufacturing costs. The company’s shares fell 3.8% to $252.20 in premarket trading. Increasing production costs have battered the auto industry’s earnings over the months. Despite taking pricing actions, automakers and parts suppliers have struggled to cover costs…

Read More

In Zimbabwe, a post-Mugabe economic revival remains elusive ahead of vote

By Nyasha Chingono HARARE (Reuters) – When Zimbabwe’s President Emmerson Mnangagwa came to power nearly six years ago after the military toppled long-time ruler Robert Mugabe, he promised to tackle the country’s economic woes “head on”. But for many, like 51-year-old widow Regina Ruona, the promised economic revival remains elusive. After braving a chilly morning…

Read More

Regeneron expects FDA decision on high-dose eye drug this year, shares jump

(Reuters) -Regeneron Pharmaceuticals expects a U.S. decision on a higher-dose version of its blockbuster eye disease drug Eylea in the third quarter, much earlier than market expectations, sending its shares 5% higher in premarket trading on Thursday. The U.S. Food and Drug Administration declined to approve a higher-dose version of Eylea in June following an…

Read More